The end of a billion-dollar drug.

“AbbVie’s Humira—a monoclonal antibody used to treat autoimmune disease—is the most financially successful drug ever to hit the market, bringing in $200 billion in revenue over its 20-year market rein.” Soon, it “will be saying goodbye to its 20-year throne of U.S. market exclusivity.” ~ learn more